Literature DB >> 27108270

A Majority of FXTAS Cases Present with Intranuclear Inclusions Within Purkinje Cells.

Jeanelle Ariza1, Hailee Rogers1, Angela Monterrubio1, Adriana Reyes-Miranda1, Paul J Hagerman2,3, Verónica Martínez-Cerdeño4,5.   

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive neurodegenerative disorder that affects carriers of a FMR1 premutation. Symptoms include cerebellar ataxia, tremor, and cognitive deficits. The most characteristic pathology of FXTAS is the presence of eosinophilic ubiquitin-positive intranuclear inclusions in neurons and astrocytes throughout the nervous system and non-nervous tissues. Inclusions are present in neurons throughout the brain but are widely believed not to be present in the Purkinje cells (PCs) of the cerebellum. However, we analyzed 26 postmortem cases of FXTAS and demonstrated that 65 % of cases presented with inclusions within PCs of the cerebellum. We determined that the presence or absence of inclusions in PCs is correlated with age and that those cases with PC inclusions were overall 11 years older than those with no PC inclusions. Half of the cases with PCs with inclusions presented with twin nuclear inclusions. This novel finding demonstrating the presence of inclusions within PCs provides an insight into the understanding of the FXTAS motor symptoms and provides a novel target for the development of therapeutic strategies.

Entities:  

Keywords:  Cerebellum; FRMP; FXTAS; Purkinje cells; Ubiquitin

Mesh:

Year:  2016        PMID: 27108270     DOI: 10.1007/s12311-016-0776-y

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  17 in total

Review 1.  Essential tremor.

Authors:  Elan D Louis
Journal:  Lancet Neurol       Date:  2005-02       Impact factor: 44.182

2.  Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains.

Authors:  Rachel Babij; Michelle Lee; Etty Cortés; Jean-Paul G Vonsattel; Phyllis L Faust; Elan D Louis
Journal:  Brain       Date:  2013-09-12       Impact factor: 13.501

3.  Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  C M Greco; R F Berman; R M Martin; F Tassone; P H Schwartz; A Chang; B D Trapp; C Iwahashi; J Brunberg; J Grigsby; D Hessl; E J Becker; J Papazian; M A Leehey; R J Hagerman; P J Hagerman
Journal:  Brain       Date:  2005-12-05       Impact factor: 13.501

4.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.

Authors:  Rob Willemsen; Marianne Hoogeveen-Westerveld; Surya Reis; Joan Holstege; Lies-Anne W F M Severijnen; Ingeborg M Nieuwenhuizen; Mariette Schrier; Leontine van Unen; Flora Tassone; Andre T Hoogeveen; Paul J Hagerman; Edwin J Mientjes; Ben A Oostra
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

5.  Essential tremor associated with pathologic changes in the cerebellum.

Authors:  Elan D Louis; Jean Paul G Vonsattel; Lawrence S Honig; Arlene Lawton; Carol Moskowitz; Blair Ford; Steven Frucht
Journal:  Arch Neurol       Date:  2006-08

6.  Reversibility of neuropathology and motor deficits in an inducible mouse model for FXTAS.

Authors:  Renate K Hukema; Ronald A M Buijsen; Martijn Schonewille; Chris Raske; Lies-Anne W F M Severijnen; Ingeborg Nieuwenhuizen-Bakker; Rob F M Verhagen; Lisanne van Dessel; Alex Maas; Nicolas Charlet-Berguerand; Chris I De Zeeuw; Paul J Hagerman; Robert F Berman; Rob Willemsen
Journal:  Hum Mol Genet       Date:  2015-06-09       Impact factor: 6.150

Review 7.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

8.  Ectopic expression of CGG containing mRNA is neurotoxic in mammals.

Authors:  Vera Hashem; Jocelyn N Galloway; Mayra Mori; Rob Willemsen; Ben A Oostra; Richard Paylor; David L Nelson
Journal:  Hum Mol Genet       Date:  2009-04-18       Impact factor: 6.150

9.  Fragile X-Associated Tremor/Ataxia Syndrome in a Man in His 30s.

Authors:  Verónica Martínez-Cerdeño; Mirna Lechpammer; Aisha Lott; Andrea Schneider; Randi Hagerman
Journal:  JAMA Neurol       Date:  2015-09       Impact factor: 18.302

10.  Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen A Leehey; Deborah A Hall; Richard A Levine; James A Brunberg; Lin Zhang; Tristan Jardini; Louise W Gane; Susan W Harris; Kristin Herman; James Grigsby; Claudia M Greco; Elizabeth Berry-Kravis; Flora Tassone; Paul J Hagerman
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

View more
  17 in total

Review 1.  Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.

Authors:  Teresa Botta-Orfila; Gian Gaetano Tartaglia; Aubin Michalon
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

Review 2.  [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

Authors:  M J Salcedo-Arellano; R J Hagerman; V Martinez-Cerdeno
Journal:  Rev Neurol       Date:  2019-03-01       Impact factor: 0.870

3.  Can a Neurosteroid Ameliorate Fragile X-Associated Tremor/Ataxia Syndrome?

Authors:  Dejan B Budimirovic
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

4.  Metabolic pathways modulate the neuronal toxicity associated with fragile X-associated tremor/ataxia syndrome.

Authors:  Ha Eun Kong; Junghwa Lim; Feiran Zhang; Luoxiu Huang; Yanghong Gu; David L Nelson; Emily G Allen; Peng Jin
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

5.  Iron accumulation and dysregulation in the putamen in fragile X-associated tremor/ataxia syndrome.

Authors:  Jeanelle Ariza; Hailee Rogers; Anna Hartvigsen; Melissa Snell; Michael Dill; Derek Judd; Paul Hagerman; Verónica Martínez-Cerdeño
Journal:  Mov Disord       Date:  2017-02-24       Impact factor: 10.338

Review 6.  Repeat-associated non-AUG (RAN) translation: insights from pathology.

Authors:  Monica Banez-Coronel; Laura P W Ranum
Journal:  Lab Invest       Date:  2019-03-27       Impact factor: 5.662

7.  Two FMR1 premutation cases without nuclear inclusions.

Authors:  Verónica Martínez-Cerdeño; Mirna Lechpammer; Paul J Hagerman; Randi Hagerman
Journal:  Mov Disord       Date:  2017-06-01       Impact factor: 10.338

Review 8.  Fragile X syndrome and associated disorders: Clinical aspects and pathology.

Authors:  Maria Jimena Salcedo-Arellano; Brett Dufour; Yingratana McLennan; Veronica Martinez-Cerdeno; Randi Hagerman
Journal:  Neurobiol Dis       Date:  2020-01-10       Impact factor: 7.046

9.  Cerebellar-cortical function and connectivity during sensorimotor behavior in aging FMR1 gene premutation carriers.

Authors:  Walker S McKinney; James Bartolotti; Pravin Khemani; Jun Yi Wang; Randi J Hagerman; Matthew W Mosconi
Journal:  Neuroimage Clin       Date:  2020-07-02       Impact factor: 4.881

Review 10.  Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in Fragile X Tremor Ataxia Syndrome.

Authors:  M Rebecca Glineburg; Peter K Todd; Nicolas Charlet-Berguerand; Chantal Sellier
Journal:  Brain Res       Date:  2018-02-14       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.